Literature DB >> 16861120

Minimally invasive approaches to localized prostate carcinoma.

Robert L Grubb1, Itay Y Vardi, Sam B Bhayani, Adam S Kibel.   

Abstract

Prostate cancer is an increasing medical problem. Radical prostatectomy and radiation therapy are effective treatments, but have the risk of significant morbidity. Clinicians have strived to develop new modalities of treatment that can maintain the excellent treatment outcomes of radical prostatectomy, but diminish the morbidity. Improved instrumentation, optics, and robotic technology have allowed the application of laparoscopic techniques to radical prostatectomy. Patients can have less blood loss and expect more rapid recovery. Intermediate oncologic outcomes appear similar to radical prostatectomy with good functional results. Cryotherapy and HIFU are tissue ablative approaches rather than extirpative approaches to prostate cancer treatment. They attempt to use nonsurgical methods to treat prostate cancer with the hope of providing oncologic control comparable to surgery and radiation while minimizing morbidity.

Entities:  

Mesh:

Year:  2006        PMID: 16861120     DOI: 10.1016/j.hoc.2006.03.008

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  4 in total

Review 1.  Novel techniques for the treatment of localized prostate cancer: evidence of efficacy?

Authors:  Marnie R Robinson; Judd W Moul
Journal:  Curr Urol Rep       Date:  2007-05       Impact factor: 3.092

2.  Vitamin D(3) cryosensitization increases prostate cancer susceptibility to cryoablation via mitochondrial-mediated apoptosis and necrosis.

Authors:  John M Baust; Daniel P Klossner; Anthony Robilotto; Robert G Vanbuskirk; Andrew A Gage; Vladimir Mouraviev; Thomas J Polascik; John G Baust
Journal:  BJU Int       Date:  2011-08-26       Impact factor: 5.588

Review 3.  Imaging techniques for prostate cancer: implications for focal therapy.

Authors:  Baris Turkbey; Peter A Pinto; Peter L Choyke
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

4.  Integrin involvement in freeze resistance of androgen-insensitive prostate cancer.

Authors:  J G Baust; D P Klossner; R G Vanbuskirk; A A Gage; V Mouraviev; T J Polascik; J M Baust
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-01-12       Impact factor: 5.554

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.